 - Alpha-fetoprotein 20 ngmL and ultrasound or other imaging with no evidence of hepatocellular carcinoma HCC, or alpha-fetoprotein of 21-50 ngmL and computed tomography CTmagnetic resonance imaging MRI scan with no evidence of HCC, within 6 months of screening 